Clinical trials
Observational Lymphoma, Large B-Cell, Diffuse trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2007 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Unknown status | 4 |
| Active, not recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hospices Civils de Lyon | 4 |
| MorphoSys AG | 2 |
| Regeneron Pharmaceuticals | 2 |
| University Hospital, Bordeaux | 2 |
| University Hospital, Montpellier | 2 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Centre Hospitalier Universitaire Dijon | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Novartis Pharmaceuticals | 1 |
| OWKIN | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Large B-Cell, Diffuse | 20 |
| Lymphoma, Follicular | 6 |
| Lymphoma, Non-Hodgkin | 4 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 |
| Lymphoma, B-Cell, Marginal Zone | 3 |
| Neoplasms | 3 |
| Breast Neoplasms | 2 |
| Burkitt Lymphoma | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Hodgkin Disease | 2 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.